Back

Predictors of survival in decompensated HfpEF with moderate aortic stenosis

12 May 2024 (16:25 - 16:34)
Organised by: Logo
Congress Presentation Part of: Improving prognosis in aortic valve disease Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Monika Shumkova

UMHAT Alexandrovska Hospital, Sofia (Bulgaria)

6 More presentations in this session

Presentation thumbnail
Myocardial work predicts left ventricular dysfunction following transcatheter aortic valve replacement in patients with aortic valve stenosis
Doctor M. Vanderheyden (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Myocardial work assessment for immediate changes in left ventricular function and survival analysis after transcatheter aortic valve replacement
Miss A. Moya (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of non-severe paravalvular leak after transcatheter aortic valve implantation.
Doctor B. Lacerda Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Histological tissue characterization of myocardial remodelling in endomyocardial biopsies from patients with severe aortic valvular disease
Miss L. Tapia (Pamplona, Navarra, ES)
Abstract Slides Video
Presentation thumbnail
Pulmonary congestion assessed by lung ultrasound in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: prevalence and prognostic implications
Doctor F. Graziani (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Improving prognosis in aortic valve disease
Video

The Event

Event poster

Heart Failure 2024

12 May 2024 16:25 CET
You may be interested in
thumbnail
Congress Presentation
Continuation of beta-blockers at discharge is associated with improved outcome in patients with HFpEF and concomitant moderate aortic stenosis
thumbnail
Congress Presentation
Severe aortic stenosis portends adverse outcomes in patients with acute heart failure
thumbnail
Congress Presentation
One-year prognostic markers for all-cause mortality in elderly patients with acute heart failure and preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources